Published in J Diabetes Sci Technol on July 01, 2010
Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab Res Rev (2013) 1.43
Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study. Diabetes (2014) 1.01
Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study. Sci Rep (2016) 0.78
Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics. J Perinatol (2011) 0.77
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet (2009) 10.02
GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med (2008) 5.74
The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr Diabetes (2007) 3.69
Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun (2008) 3.48
Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia (1996) 3.23
The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci (2008) 2.65
Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics (2008) 2.56
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin Immunol (2009) 2.30
Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes (2009) 2.02
Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia (2008) 2.01
Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care (2004) 1.65
The accelerating epidemic of childhood diabetes. Lancet (2009) 1.45
TEDDY--The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann N Y Acad Sci (2006) 1.40
A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther (2007) 1.23
Vitamin D in type 1 diabetes prevention. J Nutr (2005) 1.07
Estimation of genetic risk for type 1 diabetes. Am J Med Genet (2002) 1.06
Time-resolved fluorometry based sandwich hybridisation assay for HLA-DQA1 typing. Dis Markers (1998) 0.96
The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J Clin Invest (2010) 0.93
Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). Diabetes Metab Res Rev (2004) 0.93
Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure. Ann N Y Acad Sci (2003) 0.88
Hidden population substructures in an apparently homogeneous population bias association studies. Eur J Hum Genet (2006) 0.85
A screening system for detecting genetic risk markers of type 1 diabetes in dried blood spots. Diabetes Technol Ther (2006) 0.83
Cord blood islet autoantibodies are related to stress in the mother during pregnancy. Ann N Y Acad Sci (2006) 0.79
Immunology of diabetes V: from bench to bedside. Proceedings of the 9th International Congress of the Immunology of Diabetes Society. November 14-18, 2007. Miami, Florida, USA. Ann N Y Acad Sci (2008) 0.78
The NIH Human Microbiome Project. Genome Res (2009) 24.61
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab (2002) 13.06
Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med (2014) 5.44
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr (2003) 3.14
Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol (2006) 3.12
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab (2010) 2.70
Insulin secretion in type 1 diabetes. Diabetes (2004) 2.59
A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes (2008) 2.51
The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes (2011) 2.44
Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet Med (2011) 2.41
Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr (2006) 2.36
Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes (2009) 2.02
Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes (2002) 1.89
Genetics of type 1 diabetes: what's next? Diabetes (2010) 1.80
Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin Chem (2008) 1.71
HLA genotyping in the international Type 1 Diabetes Genetics Consortium. Clin Trials (2010) 1.61
Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care (2002) 1.59
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Mol Genet Metab (2009) 1.44
Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs. Diabetes (2011) 1.44
Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clin Trials (2010) 1.44
Report from a workshop on multianalyte microsphere assays. Cytometry (2002) 1.43
Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab Res Rev (2013) 1.43
Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium. Clin Trials (2010) 1.42
TEDDY--The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann N Y Acad Sci (2006) 1.40
Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories. Clin Trials (2010) 1.33
B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom (2003) 1.26
Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease Control and Prevention. Semin Perinatol (2010) 1.21
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia (2015) 1.20
Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes (2012) 1.19
Quality control of phenotypic forms data in the Type 1 Diabetes Genetics Consortium. Clin Trials (2010) 1.19
Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom (2007) 1.18
Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. Clin Chim Acta (2010) 1.11
Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials (2010) 1.10
National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev (2006) 1.10
Formalization of the MESF unit of fluorescence intensity. Cytometry B Clin Cytom (2004) 1.10
Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. J Med Screen (2006) 1.07
Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters. Clin Chim Acta (2009) 1.05
Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children. J Autoimmun (2011) 1.04
Frequency-domain measurement of the photodegradation process of fluorescein. Photochem Photobiol (2002) 1.03
Overview of monoclonal B-cell lymphocytosis. Br J Haematol (2007) 1.00
Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes. Diabetes (2012) 1.00
Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes (2013) 0.99
Prevalence of congenital hypothyroidism--current trends and future directions: workshop summary. Pediatrics (2010) 0.98
Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+ CD25+ regulatory T cells. Blood (2005) 0.96
Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding. Blood (2013) 0.96
Preliminary proficiency testing results for succinylacetone in dried blood spots for newborn screening for tyrosinemia type I. Clin Chem (2009) 0.93
Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry B Clin Cytom (2010) 0.92
Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM). Clin Chim Acta (2010) 0.92
Newborn Screening System Performance Evaluation Assessment Scheme (PEAS). Semin Perinatol (2010) 0.92
Naming and counting disorders (conditions) included in newborn screening panels. Pediatrics (2006) 0.91
Newborn bloodspot screening for lysosomal storage disorders. J Pediatr (2011) 0.91
Azide and Tween-20 reduce binding to autoantibody epitopes of islet antigen-2; implications for assay performance and reproducibility. J Immunol Methods (2009) 0.91
Quantification of malonylcarnitine in dried blood spots by use of MS/MS varies by stable isotope internal standard composition. Clin Chim Acta (2008) 0.90
Detection of TPN contamination of dried blood spots used in newborn and metabolic screening and its impact on quantitative measurement of amino acids. Clin Chim Acta (2011) 0.90
Performance properties of filter paper devices for whole blood collection. Bioanalysis (2010) 0.88
HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes. Pediatr Diabetes (2011) 0.86
Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells. Cytometry B Clin Cytom (2006) 0.86
Onset features and subsequent clinical evolution of childhood diabetes over several years. Pediatr Diabetes (2011) 0.85
Tandem mass spectrometric identification of dextrose markers in dried-blood spots from infants receiving total parenteral nutrition. Clin Chim Acta (2010) 0.84
Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening. Mol Genet Metab (2012) 0.84
A screening system for detecting genetic risk markers of type 1 diabetes in dried blood spots. Diabetes Technol Ther (2006) 0.83
Newborn dried blood spot screening: residual specimen storage issues. Pediatrics (2012) 0.83
Sequence variants in the PLEKHH2 region are associated with diabetic nephropathy in the GoKinD study population. Hum Genet (2008) 0.82
Assessment of DNA contamination from dried blood spots and determination of DNA yield and function using archival newborn dried blood spots. Clin Chim Acta (2008) 0.82
Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening. Clin Chim Acta (2011) 0.82
Polymorphism scan for differences between transmitted and nontransmitted DRB1*030101 alleles outside of exon 2 for type 1 diabetes: the frequency of polymorphisms is similar. Hum Immunol (2004) 0.81
Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies. Cytometry B Clin Cytom (2010) 0.80
Dried blood spot quality control materials for newborn screening to detect lysosomal storage disorders. Clin Chem (2013) 0.79
Metabolic disorders detectable by tandem mass spectrometry and unexpected early childhood mortality: a population-based study. Am J Med Genet A (2006) 0.79
Evolution of a precursor. Cytometry B Clin Cytom (2010) 0.79
NIH research to prevent type 1 diabetes: George Eisenbarth's legacy. Diabetes Technol Ther (2013) 0.78
Association of a polymorphism in the betacellulin gene with type 1 diabetes mellitus in two populations. J Mol Med (Berl) (2006) 0.78
Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Metab Res Rev (2014) 0.77
Impact of second-tier testing on the effectiveness of newborn screening. Clin Chem (2010) 0.77
Reproducibility of immunological tests used to assess multiple chemical sensitivity syndrome. Clin Diagn Lab Immunol (2003) 0.76
MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus. Ann N Y Acad Sci (2006) 0.76
Proficiency testing outcomes of 3-hydroxyisovalerylcarnitine measurements by tandem mass spectrometry in newborn screening. Clin Chim Acta (2010) 0.76
Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection. Cytometry B Clin Cytom (2010) 0.76
Maternal and neonatal vitamin B12 deficiency detected through expanded newborn screening--United States, 2003-2007. J Pediatr (2010) 0.76
The secret lives of monoclonal B cells. N Engl J Med (2009) 0.75
Newborn screening and type 1 diabetes: historical perspective and current activities at the CDC Division of Laboratory Sciences. Diabetes Technol Ther (2003) 0.75
Identification of two novel DQA1 alleles, DQA1*0107 and DQA1*0602, by sequence-based typing in the GoKinD population. Hum Immunol (2006) 0.75
Clinical quantitative flow cytometry: "Identifying the optimal methods for clinical quantitative flow cytometry". Cytometry B Clin Cytom (2003) 0.75
B cells behaving badly. Br J Haematol (2007) 0.75
Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening. Clin Chim Acta (2010) 0.75
Potential loss of methionine following extended storage of newborn screening samples prepared for tandem mass spectrometry analysis. Clin Chim Acta (2010) 0.75
Changes in solvent composition in tandem mass spectrometry multiplex assay for lysosomal storage disorders do not affect assay results. Clin Chem (2009) 0.75
Novel human leukocyte antigen class I and class II alleles identified by sequence-based typing in the Genetics of Kidneys in Diabetes (GoKinD) study population. Hum Immunol (2009) 0.75